Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

RID MOUSSE

PIPERONYL BUTOXIDE; PYRETHRINS

Standard Dose
4%;EQ 0.33% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview RID MOUSSE is listed in Drugs@FDA under application 021043 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PIPERONYL BUTOXIDE; PYRETHRINS Form and strength AEROSOL;TOPICAL - 4%;EQ 0.33% BASE Sponsor BAYER HEALTHCARE LLC Submission history Latest submission status date: 2006-05-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview RID MOUSSE is listed in Drugs@FDA under application 021043 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PIPERONYL BUTOXIDE; PYRETHRINS Form and strength AEROSOL;TOPICAL - 4%;EQ 0.33% BASE Sponsor BAYER HEALTHCARE LLC Submission history Latest submission status date: 2006-05-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.